The Stars Have Aligned For The 12% Yield At NewLake Capital

Impact · against what's priced in

NewLake Capital presents a bullish case based on high yield and regulatory tailwinds. The rescheduling of medical cannabis provides a potential re-rating catalyst for the tenant base, supported by a conservative balance sheet.

NLCP+0.60

No priced-in read yet

In context

The rescheduling of medical cannabis serves as a catalyst for tenant profitability, while a 12% dividend yield and net cash balance sheet provide a strong valuation floor.

Read from the article alone

• net lease▲150%
• NLCP
• balance sheet
• cannabis
• dividend yield
• medical cannabis
• regulatory change
• reit

Top 1 mover · tap to explore